RxDoctor Payments DataLook up a doctor →

James Tumlin, MD

Nephrology · Lawrenceville, GANPI 1467418053

Payments from drug & device makers

$19,758,115in general payments, 2019–2025

Across 1,401 payments — averaging $14,103 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$10.2M
  • Novartis$4.5M
  • Mallinckrodt Hospital Products Inc.$1.6M
  • Vertex$1.2M
  • Akebia Therapeutics Inc$410K
  • Genentech, Inc.$367K
  • plus $1.6M from 37 others
$22,083in research payments, 2019–2025

Across 7 payments — averaging $3154.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Co., Ltd.$19K
  • F. Hoffmann-la Roche AG$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$19,758,115 in reported general payments places this provider in the 95th percentile of 388 nephrology providers in Georgia.

See all nephrology providers in Georgia

Medicare billing

Part B allowed, 2024
$40,907
Medicare patients
95
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Lawrenceville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →